Related Experiment Videos
Pneumococcal bacteraemia--a continuing challenge
Insights
Pneumococcal bacteraemia disproportionately affects elderly males, with a high fatality rate, especially in older adults. Prevention strategies are crucial given that most deaths occur early in treatment.
Area of Science:
- Infectious Diseases
- Epidemiology
- Bacteriology
Background:
- Pneumococcal bacteraemia is a significant cause of morbidity and mortality.
- Understanding risk factors and outcomes is essential for effective public health interventions.
Purpose of the Study:
- To analyze the epidemiology and clinical characteristics of pneumococcal bacteraemia.
- To identify high-risk populations and factors associated with mortality.
Main Methods:
- Retrospective analysis of 103 cases of pneumococcal bacteraemia over an eight-year period.
- Data collection included patient demographics, comorbidities, treatment, and outcomes.
Main Results:
- Elderly males were disproportionately affected.
- Overall case fatality rate was 34%, with higher rates in the elderly (42%).
- Comorbidities like respiratory, metabolic, and immune disorders, and asplenia were noted, particularly in children.
Conclusions:
- Pneumococcal bacteraemia presents a substantial risk, particularly to elderly males.
- Early mortality suggests a need for prompt and effective interventions.
- Further research into prevention strategies for high-risk groups is warranted.
Abstract:
In a retrospective study of pneumococcal bacteraemia in a large district hospital over an eight-year period 103 cases were identified. Although all age groups were represented, an unexpectedly large number of cases occurred among elderly males. The overall case fatality rate was 34 per cent, ranging from 13 per cent in children to 42 per cent in the elderly. Most children had preexisting disease and did have pneumonia. Pre-existing diseases were of three main types: (i) disorders of the respiratory system; (ii) disorders of metabolism; (iii) disorders of the immune system. Six patients had no spleen. Almost all patients received appropriate antibiotics. Most deaths occurred during the first 48 h of treatment. The prospects for the prevention of fatal pneumococcal bacteraemia are reviewed in the light of these findings.